| Nasdaq: KOOL
ThermoGenesis Corp. develops and manufactures automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products. Its products automate the volume reduction and cryopreservation process of adult stem cells and growth factors from cord blood, peripheral blood and bone marrow for use in laboratory and point of care settings. The company's core offerings include AXP AutoXpress Platform, BioArchive and Res-Q 60 BMC. The AXP AutoXpress Platform includes AXP and MarrowXpress (MXP) and companion sterile blood processing disposables for harvesting stem cells in closed systems. The AXP device is used for the processing of cord blood. The MXP is used for the preparation of cell concentrates, including stem cells from bone marrow aspirates in the laboratory setting. The BioArchive System is an automated cryogenic device used by cord blood banks for the cryopreservation and archiving of cord blood stem cell units for transplant. The Res-Q 60 BMC is a point-of-care system designed for the preparation of cell concentrates, including stem cells, from bone marrow aspirates and whole blood for platelet rich plasma. In addition, ThermoGenesis markets the Thermoline product line, which includes the ultra-rapid plasma Thermoline Freezer and Thermoline Thawer. The company was founded in 1986 and is headquartered in Rancho Cordova, CA.